These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7449980)

  • 1. [Pharmacological properties of indolylalkyl derivatives of quipazine].
    Trubitsyna TK; Kashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(5):530-6. PubMed ID: 7449980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative anorexigenic activity and other pharmacological properties of quipazine and its N-acyl derivatives].
    Trubitsyna TK; Asnina VV; Mashkovskiĭ MD
    Farmakol Toksikol; 1986; 49(1):44-9. PubMed ID: 3948987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Excellence of quipazine in the characterization of serotoninergic receptors and mechanisms].
    Hong E
    Gac Med Mex; 1982 Apr; 118(4):158-64. PubMed ID: 7117731
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticholinergic, antihistaminic and cardiovascular effects of two new congeners of quipazine and trazodone.
    Alhaider AA
    Arzneimittelforschung; 1993 Nov; 43(11):1141-4. PubMed ID: 7904818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. II. Pharmacological studies with derivatives of 2-aminotetralin, benzhydro[f]quinoline, benzhydro[g]quinoline, apomorphine and clonidine suggest a pharmacological dissimilarity between peripheral presynaptic dopamine receptors and alpha-2 adrenoceptors.
    Maixner W; Flynn JR; Arnerić SP; Cannon JG; Long JP
    J Pharmacol Exp Ther; 1983 Feb; 224(2):352-8. PubMed ID: 6296357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of 5-hydroxytryptamine (5-HT) receptors by quipazine [proceedings].
    Lansdown MR; Nash HL; Preston PR; Wallis DI
    Br J Pharmacol; 1979 May; 66(1):80P-81P. PubMed ID: 454965
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological properties of some p-chlorophenoxyacetic acid derivatives].
    Zakharevskiĭ AS; Shadurskiĭ KS
    Farmakol Toksikol; 1975; 38(2):154-9. PubMed ID: 1227878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacology of the venom from the scorpion, Buthus eupeus].
    Orlov BN; Egorov VV; Gelashvili DB; Omarov ShM
    Farmakol Toksikol; 1980; 43(6):730-3. PubMed ID: 6969666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New hybrids of quipazine and trazodone as selective inhibitors of uptake of 5-hydroxytryptamine.
    Alhaider AA
    J Pharm Sci; 1992 Jan; 81(1):99-103. PubMed ID: 1320118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat anococcygeus: a dynamic smooth muscle preparation for experimental pharmacology.
    Kulkarni SK; Sharma A
    Methods Find Exp Clin Pharmacol; 1994; 16(6):379-85. PubMed ID: 7837828
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neurochemical analysis of the mechanism of action of serotoninergic substances on avoidance behavior in situations of acute stress].
    Shelekhov SL; Val'dman AV
    Biull Eksp Biol Med; 1984 Apr; 97(4):423-6. PubMed ID: 6232963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
    Fuller RW; Snoddy HD; Mason NR; Hemrick-Luecke SK; Clemens JA
    J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced head-twitch response to quipazine of rats previously treated with methiothepin: possible involvement of dopaminergic system.
    Dall'Olio R; Vaccheri A; Montanaro N
    Pharmacol Biochem Behav; 1985 Jul; 23(1):43-8. PubMed ID: 2994121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic activation of the central pattern generator for locomotion by l-beta-3,4-dihydroxyphenylalanine and quipazine in adult paraplegic mice.
    Guertin PA
    Neurosci Lett; 2004 Mar; 358(2):71-4. PubMed ID: 15026151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the pharmacology of quipazine maleate. 3. Possible analogies between serotonin and quipazine maleate].
    Pardo EG; Hong E; Sancillo LF; Vargas R
    Gac Med Mex; 1969 Aug; 99(8):758-64. PubMed ID: 5822129
    [No Abstract]   [Full Text] [Related]  

  • 18. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacology of prooxen].
    Vinogradov VV; Krylov SS
    Farmakol Toksikol; 1980; 43(5):563-6. PubMed ID: 7449985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pharmacologic properties of stereoisomers of 4-vinylethynyl- and 4-butyl-substituted decahydroquinololes-4].
    Kuz'mitskiĭ BB; Akhrem AA; Ukhova LI; Marochkin AP; Bludova GV
    Farmakol Toksikol; 1972; 35(6):665-8. PubMed ID: 4405616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.